A clinical study to evaluate the usefulness of mobile phones in improving TB treatment

The development and evaluation of m-Health service in the control of Tuberculosis (TB) in India. - TIMTAM trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/07/001889

Enrollment

500

Registered

2011-07-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Tuberculosis and Tuberculosis and HIV coinfected individuals

Interventions

Intervention1: DOTS Plus mHealth: Patients in arm A (DOTS plus m-Health) will receive three text (SMS) messages every week for the duration of their treatment as a part of the trial. Patients will be

Eligibility

Inclusion criteria

Inclusion criteria: 1. Owns a mobile phone and can read text messages 2. Person with confirmed TB ( smear and/or culture) 3. Person having both TB and HIV disease 4. Should be able to sign an informed consent

Exclusion criteria

Exclusion criteria: Not able to sign the informed consent document

Design outcomes

Primary

Measure	Time frame
Treatment Adherence ratesTimepoint: Baseline, 3 and 6 months	—

Secondary

Measure	Time frame
1.Treatment completion and cure rates 2.Treatment success rates 3.Adverse drug reaction rates 4.Stigma associated with TB (measured by a validated survey) 5.Patient satisfaction (measured by a validated survey) 6.Usage of the m-health initiative Timepoint: Baseline, 3 and 6 months	—

Countries

India

Contacts

Public ContactDilip Mathai

dilipmathai@yahoo.com04162282804

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026